Omair Saleh
056c47581f
Ships the second dashboard surface — a Pattern Library + Preview Theatre — that presents the 4-section PDP pilot batch back to Umar, compliance, and the board in an editorial format. Adds the full data layer that drives it: 5 source-backed per-SKU drafts at QA 100/100, 15 competitor PDP semantic extracts, PubMed evidence packs, EFSA claims library extension, JV brand voice guide, hand-curated product FAQs, and the Matrixify-ready CSV exports for Lewis. Co-Authored-By: Claude Opus 4.7 (1M context) <noreply@anthropic.com>
58 lines
2.4 KiB
JSON
58 lines
2.4 KiB
JSON
{
|
|
"sku": "JV-CRAN",
|
|
"name": "Cranberry 5000mg",
|
|
"generatedAt": "2026-05-19T15:07:03.230Z",
|
|
"generatedBy": "generate-catalog-intelligence-queues.ts",
|
|
"coverage": "catalogue_queue_seeded_from_product_record",
|
|
"evidenceStatus": {
|
|
"feefo": "catalogue_queue_not_quote_level_extracted",
|
|
"amazon": "available:1",
|
|
"reddit": "available:1",
|
|
"trustpilot": "available:1",
|
|
"note": "This file closes catalogue coverage as a workqueue/evidence scaffold only. It is not final human-approved copy and must not be treated as source-backed claim evidence."
|
|
},
|
|
"approvalStatus": "needs_human_review",
|
|
"improvements": [
|
|
{
|
|
"rank": 1,
|
|
"impact": 5,
|
|
"difficulty": "Medium",
|
|
"improvement": "Extract SKU-specific review themes before finalising PDP copy",
|
|
"productWeakness": "No quote-level customer-language evidence attached yet",
|
|
"suggestedCopy": "Do not publish final benefit copy from this queue row alone."
|
|
},
|
|
{
|
|
"rank": 2,
|
|
"impact": 5,
|
|
"difficulty": "Medium",
|
|
"improvement": "Map only source-backed/approved claims into clinically_shown_to",
|
|
"productWeakness": "Compliance approval is still blocked for most catalogue rows",
|
|
"suggestedCopy": "Use authorised claims only; avoid disease-treatment or unsupported efficacy language."
|
|
},
|
|
{
|
|
"rank": 3,
|
|
"impact": 5,
|
|
"difficulty": "Medium",
|
|
"improvement": "Produce and upload the assigned PDP visual assets",
|
|
"productWeakness": "Image audit/photo brief can only be final after the actual files exist",
|
|
"suggestedCopy": "Use the filename assignments as the production checklist, not as proof assets are live."
|
|
},
|
|
{
|
|
"rank": 4,
|
|
"impact": 3,
|
|
"difficulty": "Low",
|
|
"improvement": "Validate customer demand around: Verified customer-language extraction still required",
|
|
"productWeakness": "Benefit seed needs supporting reviews and market evidence",
|
|
"suggestedCopy": "Turn into PDP language only after supporting source rows are attached."
|
|
},
|
|
{
|
|
"rank": 5,
|
|
"impact": 3,
|
|
"difficulty": "Low",
|
|
"improvement": "Validate customer demand around: Product benefit, format, and dosage clarity need source-backed expansion",
|
|
"productWeakness": "Benefit seed needs supporting reviews and market evidence",
|
|
"suggestedCopy": "Turn into PDP language only after supporting source rows are attached."
|
|
}
|
|
]
|
|
}
|